Monitoring patients for possible QTC prolongation with psychotropic use can be difficult--even more so in children or adolescents. What screening and treatment techniques should be used for maximum therapeutic benefit with minimum cardiac risk?
Michael J. Labellarte, MD
Advertisement
Articles by Michael J. Labellarte, MD
Advertisement
Latest Updated Articles
- Assessing Risk of QTC Prolongation
Published: May 1st 2004 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
Lithium-Loaded Gold Nanoparticle Nasal Spray to Treat Neuropsychiatric Diseases
2
Preliminary Report on Dangers of AI Chatbots
3
The Trial of ChatGPT: What Psychiatrists Need to Know About AI, Suicide, and the Law
4
Suicide: Can Emergency Departments Assist in its Prevention?
5
